Trial Management STREAM

  1. Why Disclosure As A Service? 6/3/2020

    Two clinical trial sponsors – one larger pharmaceutical company and one smaller biotech – share with TrialScope what their main reasons were for initially considering Disclosure as a Service. Watch the short video.

  2. The Path Forward, Altasciences' Approach To Project Management 3/19/2024

    Learn about a unique, integrated program management strategy that can lower your costs and reduce program timelines from lead candidate selection to clinical proof-of-concept by up to 40%.

  3. Clinical Research Without Borders 5/16/2024

    Explore strategies for navigating global clinical trials with, Afshawn Chakamian of Avidity Biosciences, Dr. Amy Raymond of Worldwide Clinical Trials, Scott Schliebner of Novotech, and Scout’s KimberLee Heidmann.

  4. The Golden Era Of GLP-1 Drugs 10/8/2024

    As GLP-1 drugs reshape the market, understanding their potential risks, applications, and economic effects is crucial for professionals in the pharmaceutical and healthcare industries.

  5. Digital Physical Activity Measures In Phase 3 Immunology Trials 2/25/2025

    Dr. Jie Shen, Research Fellow and Director of Digital Science at AbbVie, shares lessons learned from incorporating digital measures of physical activity into Phase 3 immunology clinical trials.

  6. Practical Approaches To Faster Study Start-Ups 9/25/2023

    Learn how teams can leverage organizational, procedural, and technological solutions to recapture valuable days, weeks, and even months in the activation timelines of research sites.

  7. Cognitive, Pharmacodynamic Testing During FIH CNS Trials 5/22/2024

    A comprehensive review of optimal timing and methodologies for cognitive and pharmacodynamic testing during first-in-human trials on CNS-active compounds.

  8. Solving The Impossible In Glioblastoma With An AI Synthetic Control Arm 9/9/2022

    This video discusses Medicenna’s MDNA55-05 clinical trial; a single-arm, open-label, multicenter study that offers a promising opportunity to improve outcomes for recurrent glioblastoma.

  9. Patient First Solutions For Oncology 2/14/2023

    Medable, Inc's new oncology offering is an end-to-end suite that includes an extensive eCOA library, pre-built and validated DCT applications such as Total Consent and Televisit, and protocol design consulting.

  10. CAR-T Cell Therapies: Advancements In Cancer Trials & Treatment 6/19/2023

    Watch as Managing Editor of Pharmaceutical Technology Jeanne Linke Northrop talks with Tanmay Jain, Sr. Director of Trial Design Solutions within Medidata AI, about the use of CAR-T cell therapies within the oncology space.